Proteomic profiling of cellular responses to Carvedilol enantiomers in vascular smooth muscle cells by iTRAQ-coupled 2-D LC-MS/MS

Journal of Proteomics

Volumn 73, Issue 8, 2010, Pages 1601-1611

  Wang, Mingxuan ^a   Wang, Xiujuan ^a   Ching, Chi Bun ^a   Chen, Wei Ning ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

2 D LC MS MS; Calcium channels; Carvedilol; iTRAQ; Vascular smooth muscle cells

Indexed keywords

ACTIN IN AORTIC SMOOTH MUSCLE; CALCIUM BINDING PROTEIN; CALCYCLIN; CALMODULIN; CARVEDILOL; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 105; LACTADHERIN; PROTEIN S 100; PROTEIN S100 A10; PROTEIN S100 A11; PROTEOME; SMOOTH MUSCLE ACTIN; THIOREDOXIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; AORTA MEDIA; ARTICLE; CELL DEATH; CELL FUNCTION; CELL INTERACTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; ENANTIOMER; ISOBARIC TAGS FOR RELATIVE AND ABSOLUTE QUANTIFICATION; LIQUID CHROMATOGRAPHY; NUCLEOTIDE SEQUENCE; PHASE SEPARATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SMOOTH MUSCLE FIBER; TANDEM MASS SPECTROMETRY; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ACTINS; ADRENERGIC BETA-ANTAGONISTS; AMINO ACID SEQUENCE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOTTING, WESTERN; CARBAZOLES; CELL LINE; CHROMATOGRAPHY, LIQUID; GENE EXPRESSION PROFILING; MUSCLE, SMOOTH, VASCULAR; PROPANOLAMINES; PROTEOMICS; RATS; STEREOISOMERISM; TANDEM MASS SPECTROMETRY; THIOREDOXINS;

ANGINA;

EID: 77953122549     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2010.03.015     Document Type: Article

References (40)

1. Vanderhoff B.T., Ruppel H.M., and Amsterdam P.B. Carvedilol: the new role of beta blockers in congestive heart failure. Am Fam Physician 58 7 (1998) 1627-1634 41-2
2. Ruffolo R.R., and Feuerstein G.Z. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure. Symposium on cardiovascular pharmacotherapy: from prevention to treatment (1995), Kluwer Academic Publ, Santiago, Chile 247-256
3. Nichols A.J., Sulpizio A.C., Ashton D.J., Hieble J.P., and Ruffolo Jr. R.R. In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol. Pharmacology 39 5 (1989) 327-336
4. Smith C., and Teitler M. Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors. Cardiovasc Drugs Ther 13 2 (1999) 123-126
5. Yue T.L., Cheng H.Y., Lysko P.G., McKenna P.J., Feuerstein R., Gu J.L., et al. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 263 1 (1992) 92-98
6. Ruffolo Jr. R.R., Gellai M., Hieble J.P., Willette R.N., and Nichols A.J. The pharmacology of carvedilol. Eur J Clin Pharmacol 38 Suppl 2 (1990) S82-S88
7. Nichols A.J., Sulpizio A.C., Ashton D.J., Hieble J.P., and Ruffolo R.R. The interaction of the enantiomers of carvedilol with alpha-1-adrenoceptors and beta-1-adrenoceptors. Chirality 1 4 (1989) 265-270
8. Bartsch W., Sponer G., Strein K., Mullerbeckmann B., Kling L., Bohm E., et al. Pharmacological characteristics of the stereoisomers of carvedilol. Eur J Clin Pharmacol 38 (1990) S104-S107
9. Toda N. Vasodilating beta-adrenoceptor blockers as cardiovascular therapeutics. Pharmacol Ther 100 3 (2003) 215-234
10. Nakajima T., Ma J., Iida H., Iwasawa K., Jo T., Omata M., et al. Inhibitory effects of carvedilol on calcium channels in vascular smooth muscle cells. Jpn Heart J 44 6 (2003) 963-978
11. Herndon D.N., Dasu M.R., Wolfe R.R., and Barrow R.E. Gene expression profiles and protein balance in skeletal muscle of burned children after beta-adrenergic blockade. Am J Physiol Endocrinol Metab 285 4 (2003) E783-E789
12. Majeran W., Cai Y., Sun Q., and van Wijk K.J. Functional differentiation of bundle sheath and mesophyll maize chloroplasts determined by comparative proteomics. Plant Cell 17 11 (2005) 3111-3140
13. Dunkley T.P., Hester S., Shadforth I.P., Runions J., Weimar T., Hanton S.L., et al. Mapping the Arabidopsis organelle proteome. Proc Natl Acad Sci U S A 103 17 (2006) 6518-6523
14. Sarry J.E., Chen S., Collum R.P., Liang S., Peng M., Lang A., et al. Analysis of the vacuolar luminal proteome of Saccharomyces cerevisiae. FEBS J 274 16 (2007) 4287-4305
15. Sui J., Tan T.L., Zhang J., Ching C.B., and Chen W.N. iTRAQ-coupled 2D LC-MS/MS analysis on protein profile in vascular smooth muscle cells incubated with S- and R-enantiomers of propranolol: possible role of metabolic enzymes involved in cellular anabolism and antioxidant activity. J Proteome Res 6 5 (2007) 1643-1651
16. Sui J., Zhang J., Tan T.L., Ching C.B., and Chen W.N. Comparative proteomics analysis of vascular smooth muscle cells incubated with S- and R-enantiomers of atenolol using iTRAQ-coupled two-dimensional LC-MS/MS. Mol Cell Proteomics 7 6 (2008) 1007-1018
17. Zhang J., Sui J., Ching C.B., and Chen W.N. Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: possible action of induced proteins on Alzheimer's disease. Proteomics 8 8 (2008) 1595-1607
18. Shilov I.V., Seymour S.L., Patel A.A., Loboda A., Tang W.H., Keating S.P., et al. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 6 9 (2007) 1638-1655
19. Lu H., Yang Y., Allister E.M., Wijesekara N., and Wheeler M.B. The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approach. Mol Cell Proteomics 7 8 (2008) 1434-1451
20. 2+ signals. J Cell Sci 114 12 (2001) 2213-2222
21. Clapham D.E. Calcium signaling. Cell 80 2 (1995) 259-268
22. Schildmeyer L.A., Braun R., Taffet G., Debiasi M., Burns A.E., Bradley A., et al. Impaired vascular contractility and blood pressure homeostasis in the smooth muscle alpha-actin null mouse. FASEB J 14 14 (2000) 2213-2220
23. Tomasek J.J., Haaksma C.J., Schwartz R.J., Vuong D.T., Zhang S.X., Ash J.D., et al. Deletion of smooth muscle alpha-actin alters blood-retina barrier permeability and retinal function. Invest Ophthalmol Vis Sci 47 6 (2006) 2693-2700
24. 2+-binding protein family in guinea-pig smooth muscle. Cell Calcium 33 1 (2003) 1-10
25. Mani R.S., McCubbin W.D., and Kay C.M. Calcium-dependent regulation of caldesmon by an 11-kDa smooth muscle calcium-binding protein, caltropin. Biochemistry 31 47 (1992) 11896-11901
26. 2+-dependent binding of calcyclin to muscle tropomyosin. Biochem Biophys Res Commun 220 2 (1996) 360-365
27. Shimamoto S., Takata M., Tokuda M., Oohira F., Tokumitsu H., and Kobayashi R. Interactions of S100A2 and S100A6 with the tetratricopeptide repeat proteins, Hsp90/Hsp70-organizing protein and kinesin light chain. J Biol Chem 283 42 (2008) 28246-28258
28. Breen E.C., and Tang K. Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro. J Cell Biochem 88 4 (2003) 848-854
29. 2+- and phospholipid-binding protein annexin A6. Am J Physiol Cell Physiol 292 4 (2007) C1417-C1430
30. 2+-dependent association between S100C (S100A11) and its target, the N-terminal part of annexin I. Structure 8 2 (2000) 175-184
31. Rety S., Sopkova J., Renouard M., Osterloh D., Gerke V., Tabaries S., et al. The crystal structure of a complex of p11 with the annexin II N-terminal peptide. Nat Struct Biol 6 1 (1999) 89-95
32. Nakata T., Sobue K., and Hirokawa N. Conformational change and localization of calpactin I complex involved in exocytosis as revealed by quick-freeze, deep-etch electron microscopy and immunocytochemistry. J Cell Biol 110 1 (1990) 13-25
33. Arner E.S., and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267 20 (2000) 6102-6109
34. Nguyen P., Awwad R.T., Smart D.D., Spitz D.R., and Gius D. Thioredoxin reductase as a novel molecular target for cancer therapy. Cancer Lett 236 2 (2006) 164-174
35. Korge P., Honda H.M., and Weiss J.N. Regulation of the mitochondrial permeability transition by matrix Ca(2+) and voltage during anoxia/reoxygenation. Am J Physiol Cell Physiol 280 3 (2001) C517-C526
36. Akao M., O'Rourke B., Teshima Y., Seharaseyon J., and Marban E. Mechanistically distinct steps in the mitochondrial death pathway triggered by oxidative stress in cardiac myocytes. Circ Res 92 2 (2003) 186-194
37. Feuerstein G., Yue T.L., Ma X.L., and Ruffolo R. Carvedilol - a novel multiple action antihypertensive drug that provides major organ protection. Cardiovasc Drug Rev 12 2 (1994) 85-104
38. Wang R., Miura T., Harada N., Kametani R., Shibuya M., Fukagawa Y., et al. Pleiotropic effects of the beta-adrenoceptor blocker carvedilol on calcium regulation during oxidative stress-induced apoptosis in cardiomyocytes. J Pharmacol Exp Ther 318 1 (2006) 45-52
39. Yamagishi N., Saito Y., and Hatayama T. Mammalian 105 kDa heat shock family proteins suppress hydrogen peroxide-induced apoptosis through a p38 MAPK-dependent mitochondrial pathway in HeLa cells. FEBS J 275 18 (2008) 4558-4570
40. Silvestre J.S., Thery C., Hamard G., Boddaert J., Aguilar B., Delcayre A., et al. Lactadherin promotes VEGF-dependent neovascularization. Nat Med 11 5 (2005) 499-506